Rane; Dinanath F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rane; Dinanath F..The latest application filed is for "novel farnesyl protein transferase inhibitors and their use to treat cancer".

Company Profile

0.14.7

Rane; Dinanath F. - Morganville NJ
Rane, Dinanath F. - Morgansville NJ
Rane; Dinanath F. - Emerson NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Farnesyl protein transferase inhibitors and their use to treat cancer Grant 7,585,864 - Rane September 8, 2	2009-09-08
Farnesyl protein transferase inhibitors as antitumor agents Grant 7,342,016 - Zhu , et al. March 11, 2	2008-03-11
Novel farnesyl protein transferase inhibitors and their use to treat cancer App 20060154937 - Rane; Dinanath F.	2006-07-13
Novel farnesyl protein transferase inhibitors as antitumor agents App 20050059672 - Zhu, Hugh Y. ; et al.	2005-03-17
Farnesyl protein transferase inhibitors Grant 6,800,636 - Guzi , et al. October 5, 2	2004-10-05
Novel farnesyl protein transferase inhibitors as antitumor agents App 20040122018 - Zhu, Hugh Y. ; et al.	2004-06-24
Farnesyl protein transferase inhibitors Grant 6,740,661 - Taveras , et al. May 25, 2	2004-05-25
Novel farnesyl protein transferase inhibitors as antitumor agents App 20030229099 - Zhu, Hugh Y. ; et al.	2003-12-11
Farnesyl protein transferase inhibitors App 20030040520 - Guzi, Timothy ; et al.	2003-02-27
Novel farnesyl protein transferase inhibitors as antitumor agents App 20020198216 - Njoroge, F. George ; et al.	2002-12-26
Farnesyl protein transferase inhibitors App 20020103207 - Taveras, Arthur G. ; et al.	2002-08-01
Farnesyl protein transferase inhibitors Grant 6,399,615 - Guzi , et al. June 4, 2	2002-06-04
Farnesyl protein transferase inhibitors Grant 6,372,747 - Taveras , et al. April 16, 2	2002-04-16
Farnesyl protein transferase inhibitors Grant 6,362,188 - Guzi , et al. March 26, 2	2002-03-26
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,958,890 - Rane , et al. September 28, 1	1999-09-28
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase Grant 5,958,940 - Rane , et al. September 28, 1	1999-09-28
Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors Grant 5,939,416 - Rane , et al. August 17, 1	1999-08-17
Tricyclic compounds Grant 5,891,872 - Doll , et al. April 6, 1	1999-04-06
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,801,175 - Afonso , et al. September 1, 1	1998-09-01
Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof Grant 5,039,676 - Saksena , et al. August 13, 1	1991-08-13
3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore Grant 4,352,808 - Rane , et al. October 5, 1	1982-10-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.